Bio-Gate AG

Research Bio-Gate AG (BIG.DE) on Bullrun: market cap EUR 5.50M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 5.50M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 7.40M-EUR 1.16M-EUR 1.41M58.2%n/aEUR 704.93KEUR 52.54KEUR 1.53M
FY2024EUR 7.05M-EUR 1.62M-EUR 1.32M58.6%n/aEUR 296.62KEUR 0EUR 1.75M
FY2023EUR 7.25M-EUR 1.62M-EUR 1.12M53.5%-0.19EUR 1.33Mn/aEUR 3.37M
FY2022EUR 5.99M-EUR 1.81M-EUR 2.60M59.8%-0.23EUR 1.61MEUR 0EUR 4.15M
FY2021n/an/an/an/a-0.07n/aEUR 45.85Kn/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-04EUR 5.50Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Bio-Gate AG

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is based in Nuremberg, Germany.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Bio-Gate AG's market cap?

Bio-Gate AG's market capitalization is EUR 5.50M.

What does Bio-Gate AG do?

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is based in Nuremberg, Germany.